In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for ...

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma.

As part of Asthma Peak Week, the Richmond and Henrico Health Districts are encouraging anyone with asthma-like symptoms to ...

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

A 21-year-old engineering student from Delhi, suffering from severe allergic asthma and rashes, successfully underwent personalised treatment in Hyderabad. Combining immunotherapy, probiotics and ...

Asthma is a chronic inflammatory disease of the conducting airways in which many cells of the innate and adaptive immune systems act together with epithelial cells to cause bronchial hyper-reactivity ...